Among these, the findings indicate that CAFs expressing AR are sensitive to changes in androgen levels that tune their mobility and invasiveness and the properties of CAFs to alter the drug extrusion of epithelial cells through glutathione release; therefore, to overcome therapy resistance in PCa, combinatorial therapies which consider the response of stromal cells to anti-androgens and chemotherapeutics are needed. Here, AR is linked to posterior cortical atrophy.